FGFR3 and bladder transitional cell carcinoma: To further explore the relationship between MHC-II signature and the FGFR3, TP53 and RB1 gene mutations, we compared the difference in mutation sites of three genes from the MHC-H and MHC-L groups in the TCGA-BLCA cohort.